These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


619 related items for PubMed ID: 15183487

  • 1. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
    Hou H, Khan N, O'Hara JA, Grinberg OY, Dunn JF, Abajian MA, Wilmot CM, Makki M, Demidenko E, Lu S, Steffen RP, Swartz HM.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):834-43. PubMed ID: 15183487
    [Abstract] [Full Text] [Related]

  • 2. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.
    Hou H, Khan N, O'Hara JA, Grinberg OY, Dunn JF, Abajian MA, Wilmot CM, Demidenko E, Lu S, Steffen RP, Swartz HM.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1503-9. PubMed ID: 15817356
    [Abstract] [Full Text] [Related]

  • 3. The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice.
    Hou H, Khan N, Grinberg OY, Yu H, Grinberg SA, Lu S, Demidenko E, Steffen RP, Swartz HM.
    Radiat Res; 2007 Aug 01; 168(2):218-25. PubMed ID: 17638413
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET, Kelley M, Rockwell S.
    Cancer Chemother Pharmacol; 2004 Jan 01; 53(1):43-50. PubMed ID: 14574460
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13.
    Amorino GP, Lee H, Holburn GE, Paschal CB, Hercules SK, Shyr Y, Steffen RP, Choy H.
    Radiat Res; 2001 Sep 01; 156(3):294-300. PubMed ID: 11500138
    [Abstract] [Full Text] [Related]

  • 8. In vivo measurement of tissue oxygen using electron paramagnetic resonance spectroscopy with oxygen-sensitive paramagnetic particle, lithium phthalocyanine.
    Hyodo F, Matsumoto S, Hyodo E, Matsumoto A, Matsumoto K, Krishna MC.
    Methods Mol Biol; 2010 Sep 01; 610():29-39. PubMed ID: 20013170
    [Abstract] [Full Text] [Related]

  • 9. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption.
    Jordan BF, Grégoire V, Demeure RJ, Sonveaux P, Feron O, O'Hara J, Vanhulle VP, Delzenne N, Gallez B.
    Cancer Res; 2002 Jun 15; 62(12):3555-61. PubMed ID: 12068004
    [Abstract] [Full Text] [Related]

  • 10. RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs.
    Pagel PS, Hettrick DA, Montgomery MW, Kersten JR, Steffen RP, Warltier DC.
    J Pharmacol Exp Ther; 1998 Apr 15; 285(1):1-8. PubMed ID: 9535987
    [Abstract] [Full Text] [Related]

  • 11. Reduced tumor oxygenation by treatment with vinblastine.
    Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Cemazar M, Auersperg M, Swartz HM.
    Cancer Res; 2001 May 15; 61(10):4266-71. PubMed ID: 11358854
    [Abstract] [Full Text] [Related]

  • 12. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry.
    Halpern HJ, Yu C, Peric M, Barth ED, Karczmar GS, River JN, Grdina DJ, Teicher BA.
    Radiat Res; 1996 May 15; 145(5):610-8. PubMed ID: 8619027
    [Abstract] [Full Text] [Related]

  • 13. Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
    Najjar SS, Bottomley PA, Schulman SP, Waldron MM, Steffen RP, Gerstenblith G, Weiss RG.
    J Cardiovasc Magn Reson; 2005 May 15; 7(4):657-66. PubMed ID: 16136855
    [Abstract] [Full Text] [Related]

  • 14. EPR oximetry of tumors in vivo in cancer therapy.
    Sentjurc M, Cemazar M, Sersa G.
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 May 15; 60(6):1379-85. PubMed ID: 15134738
    [Abstract] [Full Text] [Related]

  • 15. The pO2 in a murine tumor after irradiation: an in vivo electron paramagnetic resonance oximetry study.
    O'Hara JA, Goda F, Liu KJ, Bacic G, Hoopes PJ, Swartz HM.
    Radiat Res; 1995 Nov 15; 144(2):222-9. PubMed ID: 7480649
    [Abstract] [Full Text] [Related]

  • 16. Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry.
    O'Hara JA, Goda F, Demidenko E, Swartz HM.
    Radiat Res; 1998 Nov 15; 150(5):549-56. PubMed ID: 9806597
    [Abstract] [Full Text] [Related]

  • 17. In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors.
    Nöth U, Rodrigues LM, Robinson SP, Jork A, Zimmermann U, Newell B, Griffiths JR.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):909-19. PubMed ID: 15465209
    [Abstract] [Full Text] [Related]

  • 18. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
    Wang HW, Putt ME, Emanuele MJ, Shin DB, Glatstein E, Yodh AG, Busch TM.
    Cancer Res; 2004 Oct 15; 64(20):7553-61. PubMed ID: 15492282
    [Abstract] [Full Text] [Related]

  • 19. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study.
    Goda F, Bacic G, O'Hara JA, Gallez B, Swartz HM, Dunn JF.
    Cancer Res; 1996 Jul 15; 56(14):3344-9. PubMed ID: 8764132
    [Abstract] [Full Text] [Related]

  • 20. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
    Rodrigues LM, Howe FA, Griffiths JR, Robinson SP.
    J Magn Reson Imaging; 2004 Apr 15; 19(4):482-8. PubMed ID: 15065173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.